120 related articles for article (PubMed ID: 37722165)
21. High-throughput salting-out-assisted liquid-liquid extraction for the simultaneous determination of atorvastatin, ortho-hydroxyatorvastatin, and para-hydroxyatorvastatin in human plasma using ultrafast liquid chromatography with tandem mass spectrometry.
Yang Y; Xu Q; Zhou L; Zhong D; Chen X
J Sep Sci; 2015 Mar; 38(6):1026-34. PubMed ID: 25581027
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous estimation of paclitaxel and erlotinib in plasma by liquid chromatography/(+) electrospray tandem mass spectrometry: application in formulation development and pharmacokinetics.
Khuroo T; Atifa U; Khuroo A; Mirza MA; Ali A; Iqbal Z
Drug Dev Ind Pharm; 2022 Jul; 48(7):292-300. PubMed ID: 35913109
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of a LC-MS/MS method for the in vitro analysis of 1-hydroxymidazolam in human liver microsomes: application for determining CYP3A4 inhibition in complex matrix mixtures.
Mooiman KD; Maas-Bakker RF; Rosing H; Beijnen JH; Schellens JH; Meijerman I
Biomed Chromatogr; 2013 Sep; 27(9):1107-16. PubMed ID: 23674377
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous determination of selected tyrosine kinase inhibitors with corticosteroids and antiemetics in rat plasma by solid phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry: Application to pharmacokinetic interaction studies.
Maher HM; Alzoman NZ; Shehata SM
J Pharm Biomed Anal; 2016 May; 124():216-227. PubMed ID: 26966895
[TBL] [Abstract][Full Text] [Related]
25. Population pharmacokinetics/pharmacodynamics of erlotinib and pharmacogenomic analysis of plasma and cerebrospinal fluid drug concentrations in Japanese patients with non-small cell lung cancer.
Fukudo M; Ikemi Y; Togashi Y; Masago K; Kim YH; Mio T; Terada T; Teramukai S; Mishima M; Inui K; Katsura T
Clin Pharmacokinet; 2013 Jul; 52(7):593-609. PubMed ID: 23532985
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and safety of erlotinib and its metabolite OSI-420 in infants and children with primary brain tumors.
Reddick SJ; Campagne O; Huang J; Onar-Thomas A; Broniscer A; Gajjar A; Stewart CF
Cancer Chemother Pharmacol; 2019 Oct; 84(4):829-838. PubMed ID: 31392390
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics, bioavailability and metabolism of cligosiban, an antagonist of oxytocin receptor, in rat by liquid chromatography hyphenated with electrospray ionization tandem mass spectrometry.
Yue X; Lu L; Liu H; Xue H
J Pharm Biomed Anal; 2019 Feb; 164():725-733. PubMed ID: 30472591
[TBL] [Abstract][Full Text] [Related]
28. Liquid chromatography - tandem mass spectrometry for the simultaneous quantitation of glipizide, cilostazol and its active metabolite 3, 4-dehydro-cilostazol in rat plasma: application for a pharmacokinetic study.
Satheeshmanikandan TR; Sridhar V; Kanthikiran VV; Swaroopkumar VV; Mukkanti K
Arzneimittelforschung; 2012 Sep; 62(9):425-32. PubMed ID: 22821721
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of a liquid chromatography-tandem mass spectrometry method for simultaneous determination of amlodipine, atorvastatin and its metabolites ortho-hydroxy atorvastatin and para-hydroxy atorvastatin in human plasma and its application in a bioequivalence study.
Zhou Y; Li J; He X; Jia M; Liu M; Li H; Xiong Z; Fan Y; Li W
J Pharm Biomed Anal; 2013 Sep; 83():101-7. PubMed ID: 23711572
[TBL] [Abstract][Full Text] [Related]
30. Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the EGFR inhibitors afatinib, erlotinib and osimertinib, the ALK inhibitor crizotinib and the VEGFR inhibitor nintedanib in human plasma from non-small cell lung cancer patients.
Reis R; Labat L; Allard M; Boudou-Rouquette P; Chapron J; Bellesoeur A; Thomas-Schoemann A; Arrondeau J; Giraud F; Alexandre J; Vidal M; Goldwasser F; Blanchet B
J Pharm Biomed Anal; 2018 Sep; 158():174-183. PubMed ID: 29883880
[TBL] [Abstract][Full Text] [Related]
31. Study the pharmacokinetics of AV-45 in rat plasma and metabolism in liver microsomes by ultra-performance liquid chromatography with mass spectrometry.
Yin W; Zhou X; Qiao J; Zhu L
Biomed Chromatogr; 2012 May; 26(5):666-71. PubMed ID: 21932381
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous quantitative detection of afatinib, erlotinib, gefitinib, icotinib, osimertinib and their metabolites in plasma samples of patients with non-small cell lung cancer using liquid chromatography-tandem mass spectrometry.
Xiong X; Zhang Y; Wang Z; Zhou C; Yang P; Du X; Yang L; Liu W
Clin Chim Acta; 2022 Feb; 527():1-10. PubMed ID: 34999058
[TBL] [Abstract][Full Text] [Related]
33. Characterization of xylazine metabolism in rat liver microsomes using liquid chromatography-hybrid triple quadrupole-linear ion trap-mass spectrometry.
Lavoie DS; Pailleux F; Vachon P; Beaudry F
Biomed Chromatogr; 2013 Jul; 27(7):882-8. PubMed ID: 23447399
[TBL] [Abstract][Full Text] [Related]
34. Simultaneous determination of amlodipine and atorvastatin with its metabolites; ortho and para hydroxy atorvastatin; in human plasma by LC-MS/MS.
Yacoub M; Awwad AA; Alawi M; Arafat T
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Feb; 917-918():36-47. PubMed ID: 23369879
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous and rapid determination of gefitinib, erlotinib and afatinib plasma levels using liquid chromatography/tandem mass spectrometry in patients with non-small-cell lung cancer.
Hayashi H; Kita Y; Iihara H; Yanase K; Ohno Y; Hirose C; Yamada M; Todoroki K; Kitaichi K; Minatoguchi S; Itoh Y; Sugiyama T
Biomed Chromatogr; 2016 Jul; 30(7):1150-1154. PubMed ID: 26525154
[TBL] [Abstract][Full Text] [Related]
36. Development of a Validated Bioanalytical UPLC-MS/MS Method for Quantification of Neratinib: A Recent Application to Pharmacokinetic Studies in Rat Plasma.
Alrobaian M; Panda SS; Afzal O; Kazmi I; Alossaimi MA; Al-Abbasi FA; Almalki WH; Soni K; Alam O; Alam MN; Rub RA; Rahman M; Beg S
J Chromatogr Sci; 2022 Jul; 60(6):551-558. PubMed ID: 34230967
[TBL] [Abstract][Full Text] [Related]
37. UHPLC-MS/MS method for determination of atorvastatin calcium in human plasma: Application to a pharmacokinetic study based on healthy volunteers with specific genotype.
Xia B; Li Y; Zhang Y; Xue M; Li X; Xu P; Xia T; Chen S
J Pharm Biomed Anal; 2018 Oct; 160():428-435. PubMed ID: 30130726
[TBL] [Abstract][Full Text] [Related]
38. UPLC-ESI-MS/MS study of the effect of green tea extract on the oral bioavailability of erlotinib and lapatinib in rats: Potential risk of pharmacokinetic interaction.
Maher HM; Alzoman NZ; Shehata SM; Abahussain AO
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Apr; 1049-1050():30-40. PubMed ID: 28260629
[TBL] [Abstract][Full Text] [Related]
39. Rapid LC-MS/MS method for the determination of 4-hydroxycholesterol/cholesterol ratio in serum as endogenous biomarker for CYP3A activity in human and foals.
Hasan M; Siegmund W; Oswald S
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1033-1034():193-199. PubMed ID: 27565568
[TBL] [Abstract][Full Text] [Related]
40. HPLC methods for studying pharmacokinetics of tivozanib and in vitro metabolic interaction with dexamethasone in rat.
Zayed AL; Hamadneh GN; Hroot JA; Mayyas A; Jaber SA; Qinna NA
J Pharm Biomed Anal; 2023 Aug; 232():115423. PubMed ID: 37146497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
